Latest news

Bioservo has completed a directed issue of approximately SEK 14 million (regulatory information)

Bioservo is investigating the prerequisites for carrying out a directed share issue (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

Analysguiden

Aktiespararna utför uppdragsanalys åt Bioservo Tecnnologies AB. Här nedan finns de senaste analyserna.